Valemetostat for Relapsed or Refractory Peripheral T-Cell Lymphomas: Primary Results from a Phase 1 Trial

Jacobsen, E; Maruyama, D; Porcu, P; Tobinai, K; Allen, PB; Ishitsuka, K; Tsukasaki, K; Kusumoto, S; Foss, FM; Yamauchi, N; Morishima, S; Imaizumi, Y; Izutsu, K; Feldman, T; Kawamata, T; Kakurai, Y; Yamauchi, H; Biserna, N; Inoue, A; Tsutsumi, S; Horwitz, SM

BLOOD, 2023; 142 ():